Prevalence and factors associated with hematuria among adult population in Tumbes, Peru
DOI:
https://doi.org/10.21142/mecp.2026.1.1.e003Keywords:
Hematuria, Prevalence, Risk factors, Adult, EpidemiologyAbstract
Objectives: To estimate the prevalence and to explore potential factors associated with hematuria in adults living in Tumbes, northern Peru. Methods: Secondary analysis using data from a population-based study conducted between 2017 and 2018. The dependent variable was hematuria, defined using a dipstick (≥1+). The potential associated factors included demographic variables (sex, age, education level, etc.), socioenvironmental variables (access to drinking water, regular work in hot environments, etc.), and clinical variables (history of lithiasis, hypertension etc.). An exploratory Poisson regression model was built to report prevalence ratios (PR) and 95% confidence intervals (95%CI). Results: Data from 1514 participants were analyzed, mean age 45.1 years, and 835 (55.2%) women. Hematuria (prevalence: 8.9%; 95%CI: 7.5%–10.5%) was more common among women (PR: 1.89; 95%CI: 1.11-3.21); among those aged 30-49 years (PR: 1.98; 95%CI: 1.03-3.79); among those with a history of nephrolithiasis (PR: 1.70; 95%CI: 1.14-2.53), with a history of leptospirosis (PR: 5.41; 95%CI: 1.73-16.99), with diabetes mellitus (PR: 1.90; 95% CI: 1.17-3.08); and in those with a moderate/severe reduced glomerular filtration rate (PR: 3.09; 95% CI: 1.28-7.48). Conclusion: Hematuria is relatively common in adults in Tumbes. Being female, aged 30 to 49 years, a history of nephrolithiasis, leptospirosis, diabetes mellitus, and a decreased glomerular filtration rate were factors associated with hematuria. Our results suggest the need to evaluate appropriate methods for identifying hematuria, especially in high-risk groups.
Downloads
References
1. Ingelfinger JR. Hematuria in Adults. N Engl J Med 2021;385(2):153-63. DOI: 10.1056/NEJMra1604481.
2. Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, et al. Glomerular Hematuria and the Utility of Urine Microscopy: A Review. Am J Kidney Dis 2022;80(3):383-92. DOI: 10.1053/j.ajkd.2022.02.022.
3. Bolenz C, Schröppel B, Eisenhardt A, Schmitz-Dräger BJ, Grimm MO. The Investigation of Hematuria. Dtsch Arztebl Int 2018;115(48):801-7. DOI: 10.3238/arztebl.2018.0801.
4. Heller MT, Tublin ME. In search of a consensus: evaluation of the patient with hematuria in an era of cost containment. AJR Am J Roentgenol 2014;202(6):1179-86. DOI: 10.2214/ AJR.13.12266.
5. Joukar F, Hassanipour S, Atefi A, Maroufizadeh S, Akhavan A, Naghipour M, et al. Prevalence and associated factors for asymptomatic microscopic hematuria in adults in the PERSIAN Guilan cohort study (PGCS). Sci Rep 2024;14(1):3452. DOI: 10.1038/s41598-024-53597-w.
6. Khosousi MJ, Mansour-Ghanaei F, Heidarzad F, Joukar F, Maroufizadeh S, Abdzadeh E, et al. Epidemiologic Profile of Microscopic Hematuria in Iran: A Systematic Review and Meta-Analysis. Iran J Public Health 2022;51(10):2194-206. DOI: 10.18502/ijph.v51i10.0978.
7. Courtemanche K, Chan P, Kassouf W. Prevalence and associated factors for dipstick microscopic hematuria in men. BMC Urol 2019;19(1):76. DOI: 10.1186/s12894-019-0505-1.
8. Ishida M, Matsuzaki K, Suzuki H, Suzuki Y, Kawamura T, Marunaka Y, et al. Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study. Int J Environ Res Public Health 2022;19(18):11466. DOI: 10.3390/ ijerph191811466.
9. Luo WP, Zhao Y, Huang X, Nie J. [Risk factors for postoperative long-term hematuria in patients with benign prostatic hyperplasia]. Zhonghua Nan Ke Xue 2022;28(5):422-6.
10. Brubaker L, Carberry C, Nardos R, Carter-Brooks C, Lowder JL. American Urogynecologic Society Best-Practice Statement: Recurrent Urinary Tract Infection in Adult Women. Female Pelvic Med Reconstr Surg 2018;24(5):321-35. DOI: 10.1097/SPV.0000000000000550.
11. Santra G. Heat Stress Nephropathy: An Emerging Epidemic of Global Warming. J Assoc Physicians India 2024;72(10):110. DOI: 10.59556/japi.72.0686.
12. Carrillo-Larco RM, Bernabé-Ortiz A. [Mortality from chronic kidney disease in Peru: national trends 2003-2015]. Rev Peru Med Exp Salud Publica 2018;35(3):409-15. DOI: 10.17843/ rpmesp.2018.353.3633.
13. Ruiz-Alejos A, Caplin B, Miranda JJ, Pearce N, Bernabé-Ortiz A. CKD and CKDu in northern Peru: a cross-sectional analysis under the DEGREE protocol. BMC Nephrol 2021;22(1):37. DOI: 10.1186/s12882-021-02239-8.
14. Instituto Nacional de Estadística e Informática. Perú: Temperatura promedio, máxima y mínima, según departamento. Lima, Perú: INEI; 2015.
15. Instituto Nacional de Estadística e Informática. Censos Nacionales 2017: XII de Población, VII de Vivienda y III de Comunidades Indígenas. Lima, Perú: INEI; 2018.
16. Caplin B, Jakobsson K, Glaser J, Nitsch D, Jha V, Singh A, et al. International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE). BMC Nephrol 2017;18(1):1. DOI: 10.1186/s12882-016-0417-1.
17. O’Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 2011;1(2):e000308. DOI: 10.1136/bmjopen-2011-.
18. Lee SG, Fralick J, Wallis CJD, Boctor M, Sholzberg M, Fralick M. Systematic review of hematuria and acute renal failure with tranexamic acid. Eur J Haematol 2022;108(6):510-7. DOI: 10.1111/ejh.13762.
19. Hansen RS, Biørn SH, Birk-Korch JB, Sheikh SP, Poulsen MH, Vinholt PJ. Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis. BJU Int 2023;131(5):530-9. DOI: 10.1111/bju.15950.
20. Gleeson MJ, Connolly J, Grainger R, McDermott TE, Butler MR. Comparison of reagent strip (dipstick) and microscopic haematuria in urological out-patients. Br J Urol 1993;72(5 Pt 1):594-6. DOI: 10.1111/j.464-410x.993.tb16215.x.
21. Hassanzadeh S, Azarmehr N, Jahanshahi A, Malekzadeh JM, Doustimotlagh AH. Prevalence of Proteinuria and Hematuria in a Rural Population in the Southwest of Iran. Saudi J Kidney Dis Transpl 2022;33(Supplement):S241-s7. DOI: 10.4103/1319- 2442.384193.
22. Sarier M, Demir M, Emek M, Turgut H. Hematuria frequency and association with abnormal urological findings in medical check-up patients. Niger J Clin Pract 2022;25(3):310-4. DOI: 10.4103/njcp.njcp_1509_21.
23. Tentori F, Stidley CA, Scavini M, Shah VO, Narva AS, Paine S, et al. Prevalence of hematuria among Zuni Indians with and without diabetes: The Zuni kidney Project. Am J Kidney Dis 2003;41(6):1195-204. DOI: 10.016/s0272-6386(03)00351-2.
24. Freitas PAC, da Silva YDS, Poloni JAT, Veronese FJV, Gonçalves LFS. Dipstick Proteinuria and Hematuria as Triggers for Manual Microscopic Review in Nephrology Patients. J Clin Med 2025;14(13):4522. DOI: 10.3390/jcm14134522.
25. Deltourbe L, Lacerda Mariano L, Hreha TN, Hunstad DA, Ingersoll MA. The impact of biological sex on diseases of the urinary tract. Mucosal Immunol 2022;15(5):857-66. DOI: 10.1038/s41385-022-00549-0.
26. Abreu PF, Requiao-Moura LR, Sesso R. [Approach to assessment of hematuria]. J Bras Nefrol 2007;29(3):158-63.
27. Song L, Maalouf NM. Nephrolithiasis (last updated: March 9, 2020). In: Feingold KR, Ahmed SF, Anawalt B, editors. Endotext. South Dartmouth (MA): MDText; 2000.
28. Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, et al. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol 2018;19(1):150. DOI: 10.1186/s12882-018-0951-0.
29. Xu L, Yu C, Chen A, Li C, Mao Y. Longitudinal Analysis of Renal Function Changes in Elderly Populations: Health Status Evaluation and Risk Factor Assessment. Clin Interv Aging 2024;19:1217-24. DOI: 10.2147/CIA.S450388.
30. Chou LF, Yang HY, Hung CC, Tian YC, Hsu SH, Yang CW. Leptospirosis kidney disease: Evolution from acute to chronic kidney disease. Biomed J 2023;46(4):100595. DOI: 10.1016/j. bj.2023.
31. Daher EF, Lima RS, Silva Júnior GB, Silva EC, Karbage NN, Kataoka RS, et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis 2010;14(1):3-10.
32. Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, et al. Environmental exposure and leptospirosis, Peru. Emerg Infect Dis 2004;10(6):1016-22. DOI: 10.3201/ eid1006.030660.
33. Kim H, Lee M, Cha MU, Nam KH, An SY, Park S, et al. Microscopic hematuria is a risk factor of incident chronic kidney disease in the Korean general population: a community-based prospective cohort study. Qjm 2018;111(6):389-97. DOI: 10.1093/ qjmed/hcy054.
34. Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, et al. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol 2025;213(5):547-57. DOI: 10.1097/ JU.0000000000004490.
35. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral - NICE guideline. London, UK: NICE; 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Medical Education & Clinical Practice

This work is licensed under a Creative Commons Attribution 4.0 International License.


